SGLT2 Inhibitors – From Medscape, The Curbsiders, And From #NephMadness 2020: SGLT2i Region

Note to myself: The resources I reviewed today are listed below. Although very interesting, I don’t believe I need to review them again. If I do want to review the mechanisms of SGLT2 Inhibitors, the best way would be to listen to The CurbsidersEpisode #204 podcast while driving in the car. To that end I’ve embedded the podcast here:

The following is from SGLT2 Inhibitors (Gliflozins), updated Jan 15, 2019 from

Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new group of oral medications used for treating type 2 diabetes The drugs work by helping the kidneys to lower blood glucose levels.

The following drugs belong to the SGLT2 inhibitors class (trade name first, generic name in brackets):

In this post I review some resources on SGLT2 Inhiitors.

I reviewed Renal Effects of SGLT2 Inhibitors: An Update [Link is to the article posted on] from Curr Opin Nephrol Hypertens. 2020;29(2):190-198.

And I’ve reviewed the following:

Excerpts from the above coming soon.

This entry was posted in Curbsiders, Diabetes, Endocrinology. Bookmark the permalink.